HCV/HIV coinfection: SOF-based regimens effective pre- and post-LT

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Sofosbuvir (SOF; Sovaldi)-based regimens are safe and effective for HCV/HIV-coinfected patients who are liver transplant (LT) candidates or recipients.
  • When combined with an NS5A inhibitor, clearance rates topped 90%.

Why this matters

  • Pre-LT therapy should be considered for HI...